Добірка наукової літератури з теми "Fibrotic and inflammatory conditions"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Fibrotic and inflammatory conditions".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Fibrotic and inflammatory conditions"
Binatti, Eleonora, Alessio Gerussi, Donatella Barisani, and Pietro Invernizzi. "The Role of Macrophages in Liver Fibrosis: New Therapeutic Opportunities." International Journal of Molecular Sciences 23, no. 12 (June 14, 2022): 6649. http://dx.doi.org/10.3390/ijms23126649.
Повний текст джерелаSgambellone, Silvia, Silvia Marri, Stefano Catarinicchia, Alessandro Pini, Dilip K. Tosh, Kenneth A. Jacobson, Emanuela Masini, Daniela Salvemini, and Laura Lucarini. "Adenosine A3 Receptor (A3AR) Agonist for the Treatment of Bleomycin-Induced Lung Fibrosis in Mice." International Journal of Molecular Sciences 23, no. 21 (November 1, 2022): 13300. http://dx.doi.org/10.3390/ijms232113300.
Повний текст джерелаFilidou, Eirini, Leonidas Kandilogiannakis, Gesthimani Tarapatzi, Michail Spathakis, Paschalis Steiropoulos, Dimitrios Mikroulis, Konstantinos Arvanitidis, Vasilis Paspaliaris, and George Kolios. "Anti-Inflammatory and Anti-Fibrotic Effect of Immortalized Mesenchymal-Stem-Cell-Derived Conditioned Medium on Human Lung Myofibroblasts and Epithelial Cells." International Journal of Molecular Sciences 23, no. 9 (April 20, 2022): 4570. http://dx.doi.org/10.3390/ijms23094570.
Повний текст джерелаZhang, Xiwen, Joseph K. Ritter, and Ningjun Li. "Sphingosine-1-phosphate pathway in renal fibrosis." American Journal of Physiology-Renal Physiology 315, no. 4 (October 1, 2018): F752—F756. http://dx.doi.org/10.1152/ajprenal.00596.2017.
Повний текст джерелаHerbelet, Sandrine, Boel De Paepe, and Jan L. De Bleecker. "Abnormal NFAT5 Physiology in Duchenne Muscular Dystrophy Fibroblasts as a Putative Explanation for the Permanent Fibrosis Formation in Duchenne Muscular Dystrophy." International Journal of Molecular Sciences 21, no. 21 (October 24, 2020): 7888. http://dx.doi.org/10.3390/ijms21217888.
Повний текст джерелаPham, Tho X., Yoojin Lee, Minkyung Bae, Siqi Hu, Hyunju Kang, Mi-Bo Kim, Young-Ki Park, and Ji-Young Lee. "Spirulina supplementation in a mouse model of diet-induced liver fibrosis reduced the pro-inflammatory response of splenocytes." British Journal of Nutrition 121, no. 7 (February 26, 2019): 748–55. http://dx.doi.org/10.1017/s0007114519000126.
Повний текст джерелаRizzi, Manuela, Stelvio Tonello, Davide D’Onghia, and Pier Paolo Sainaghi. "Gas6/TAM Axis Involvement in Modulating Inflammation and Fibrosis in COVID-19 Patients." International Journal of Molecular Sciences 24, no. 2 (January 4, 2023): 951. http://dx.doi.org/10.3390/ijms24020951.
Повний текст джерелаHortobagyi, David, Tanja Grossmann, Magdalena Tschernitz, Magdalena Grill, Andrijana Kirsch, Claus Gerstenberger, and Markus Gugatschka. "In vitro mechanical vibration down-regulates pro-inflammatory and pro-fibrotic signaling in human vocal fold fibroblasts." PLOS ONE 15, no. 11 (November 19, 2020): e0241901. http://dx.doi.org/10.1371/journal.pone.0241901.
Повний текст джерелаHazel, K., N. McGinley, A. O’Toole, and S. Keely. "P087 The role of bile acids in mediating fibrosis in inflammatory bowel disease." Journal of Crohn's and Colitis 15, Supplement_1 (May 1, 2021): S187. http://dx.doi.org/10.1093/ecco-jcc/jjab076.216.
Повний текст джерелаLaaninen, Matias, Merja Bläuer, Juhani Sand, Isto Nordback та Johanna Laukkarinen. "Difference in Early Activation of NF-κB and MCP-1 in Acinar-Cell-Rich versus Fibrotic Human Pancreas Exposed to Surgical Trauma and Hypoxia". Gastroenterology Research and Practice 2014 (2014): 1–7. http://dx.doi.org/10.1155/2014/460363.
Повний текст джерелаДисертації з теми "Fibrotic and inflammatory conditions"
Pustilnik, Leslie Royce 1964. "The pulmonary inflammatory and fibrotic response induced by glass fibers." Thesis, The University of Arizona, 1987. http://hdl.handle.net/10150/276624.
Повний текст джерелаMontague, Samantha J. "Platelet activation in trauma and other inflammatory conditions." Thesis, University of Birmingham, 2017. http://etheses.bham.ac.uk//id/eprint/7147/.
Повний текст джерелаZhang, Qing, and 張清. "Comparison of mycophenolate mofetil and cyclophosphamide on inflammatory and fibrotic processes in the pathogenesis of lupusnephritis: animal and in vitro studies." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2009. http://hub.hku.hk/bib/B43085222.
Повний текст джерелаHtwe, Su Su. "Studying the role of spatial cell distribution and substrate stiffness in inflammatory and fibrotic responses in human lung using bioengineered platforms." Thesis, University of Nottingham, 2017. http://eprints.nottingham.ac.uk/48045/.
Повний текст джерелаLee, Chung Bomy. "Theranostic nanoparticles for the management of inflammatory diseases and conditions." Thesis, Massachusetts Institute of Technology, 2017. http://hdl.handle.net/1721.1/112504.
Повний текст джерелаCataloged from PDF version of thesis.
Includes bibliographical references.
Atherosclerosis, the gradual buildup of plaques within arteries, is the main cause of cardiovascular diseases (CVDs). The World Health Organization reports that CVDs are the number one cause of death in the world. In the United States alone, around 85 million people suffer from CVDs; this is associated with a cost of over $316 billion per year and responsible for about a third of all deaths in the US. Recent findings have shown that inflammation plays a pivotal role in atherosclerosis. Although statins have traditionally been prescribed for their lipid-lowering benefits, studies have indicated that they can have other effects as well (so-called "pleiotropic effects"), including anti-inflammatory, anti-oxidant, and anti-thrombotic benefits. This thesis presents a novel theranostic (therapeutic + diagnostic) nanoparticle platform for the treatment and diagnosis of atherosclerosis. Given the anti-inflammatory effects of statins when cells are directly treated, the aim of this nanoparticle platform was to target macrophages within plaques given their central role in plaque development and progression. First, simvastatin-loaded nanoparticles were designed and optimized. The particles consisted of a biodegradable polymer core and a lipid shell. Using bulk nanoprecipitation methods, as well as microfluidic devices, the physical characteristics of the particles could be controlled and fine-tuned to meet the desired specifications: 100 to 200 nm in size, -15 to -20 mV in zeta potential, and 70%+ simvastatin loading efficiency. Imaging agents, such as iron oxide nanocrystals used for magnetic resonance imaging (MRI), were successfully incorporated into the nanoparticles and can offer diagnostic capabilities to the nanoparticles. Next, various nanoparticle formulations were shown to be therapeutically effective in cell and mice models of atherosclerosis. For instance, in vitro treatment of macrophages led to decreases in the expression of TNF-a and MCP-1 by roughly 20% and 50%, respectively. This pattern has also been observed in murine models, with researchers showing that simvastatin-loaded particles can halt plaque development (and even decrease plaque area) while reducing the expression of pro-inflammatory genes (e.g., of TNF-a, IL- IP) by an order of magnitude. Overall, this thesis presents a new and innovative nanoparticle platform that has the potential for the simultaneous treatment and diagnosis of atherosclerosis. Given their anti-inflammatory benefits, these nanoparticles have the potential to impact the treatment of not only atherosclerosis but also various other inflammatory conditions and diseases as well.
by Bomy Lee Chung.
Ph. D.
Zhang, Qing. "Comparison of mycophenolate mofetil and cyclophosphamide on inflammatory and fibrotic processes in the pathogenesis of lupus nephritis : animal and in vitro studies /." Click to view the E-thesis via HKUTO, 2009. http://sunzi.lib.hku.hk/hkuto/record/B43085222.
Повний текст джерелаZhang, Chenzhu, and 张辰珠. "The effects of rapamycin and mycophenolic acid on inflammatory and fibrotic processes in the pathogenesis of lupus nephritis: animal and in vitro studies." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2011. http://hub.hku.hk/bib/B45898935.
Повний текст джерелаCollins, John Samuel Andrew. "A morphometric study of inflammatory conditions of the upper gastrointestinal tract." Thesis, Queen's University Belfast, 1988. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.336208.
Повний текст джерелаIsebor, Peter. "Positive psychological interventions in chronic conditions : gratitude and inflammatory bowel disease." Thesis, University of Sheffield, 2018. http://etheses.whiterose.ac.uk/21308/.
Повний текст джерелаPetit, Maxime. "Residency and trafficking of ILC2 in steady steate and th2 induced inflammatory conditions." Thesis, Université de Paris (2019-....), 2019. http://www.theses.fr/2019UNIP7095.
Повний текст джерелаILC2s are found in mucosal tissues as lung and intestine, in lymph nodes, and in metabolic tissues such as the adipose tissues. They play important role in maintaining or inducing type-2 immune responses as innate equivalent of Th2 lymphocytes. They are activated by alarmins (IL-25 and IL-33) and by external activators (allergens, metabolites and neuromediators). ILC2s are secreting type-2 cytokines to facilitate the activation of other cells and to induce an important repair program. Their activation allows large type of events as diverse as myeloid cells recruitment and activation, mucus production, muscle contractility and tissue repair. They have key role in lung and adipose tissue development and maintain their homeostasis by early responding against parasitic pathogens. Abnormal activation of ILC2s is also participating to chronic diseases.ILCs are mostly considered as resident cells. However, different studies suggested that migration could be important for the maturation of their effector capacities and to correctly target the injured tissue. Circulation and trafficking of ILC subsets is still unclear. No mechanism is yet available to explain the turnover of ILC2s and how they can act in many tissues following stimuli.We found that large numbers of mature and immature ILC2s could be collected in the thoracic duct lymph of mice perfused over several hours, showing that ILC2s are in fact actively circulating through the hemo-lymphatic circuit. Furthermore, circulating mature ILC2s could be separated into three distinct subsets depending on their pattern of receptor and adhesion molecule expression. Cell transfer experiments proved that specific patterns are representative of specific tropism for gut, lung and adipose tissues.To analyse ILC2 behaviour in the context of a type-2 response, we injected IL-25 and IL-33 before lymph collection. IL-33 stimulation largely enhanced the number of circulating ILC2s in the lymph. These different ILC2 tissue targeted subsets responded differently to IL-33. Specifically, gut-trafficking ILC2s were mainly stimulated to proliferate whereas lung and adipose tissue subsets were stimulated to produce IL-13, IL-5 and Areg. This suggests that, in ILC2s, specific tissue targeting is associated with already imprinted functions while transiting through the hemo-lymphatic system. We confirmed these functions of circulating ILC2 subsets in more physiological context by mimicking allergy and helminth infection (stimulation by papain and succinate) where specific migration to lungs and intestine play important roles in mounting the type-2 response by IL-5/IL-13 secretion, and also initiating tissue repair by Areg production. Interestingly, we showed that lung migrating ILC2s participated to resident pool renewal that main function is Areg production. Finally, we characterized important trafficking of ILC2 at different stages of Nippostrongulus brasiliensis infection, confirming the functional relevance of ILC2 trafficking
Книги з теми "Fibrotic and inflammatory conditions"
Inflammatory conditions of the colon. New York: Nova Science Publishers, 2009.
Знайти повний текст джерелаChurch, Martin, and Clive Robinson, eds. Eicosanoids in Inflammatory Conditions of the Lung, Skin and Joints. Dordrecht: Springer Netherlands, 1988. http://dx.doi.org/10.1007/978-94-009-1283-0.
Повний текст джерела1942-, Bonney R. J., ed. Inflammatory disease therapy: Preclinical and clinical developments. Basel: Birkhäuser Verlag, 1993.
Знайти повний текст джерелаHashefi, Mandana. PET/CT applications in non-neoplastic conditions. Edited by New York Academy of Sciences. Boston, Mass: Published by Blackwell Pub. on behalf of the New York Academy of Sciences, 2011.
Знайти повний текст джерелаBlack, Jessica K. Eating your way back to health: A guide to inflammatory cooking - reduce inflammation to help heal cardiovascular disease, arthritis, fibromyalgia, diabetes, allergies, and many more conditions. McMinnville, Ore: A Family Healing Center, 2004.
Знайти повний текст джерелаYaqoob, Muhammad M., Katherine Bennett-Richards, and Islam Junaid. Retroperitoneal fibrosis. Edited by Adrian Woolf. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199592548.003.0357.
Повний текст джерелаRecipes for the Specific Carbohydrate Diet: The Grain-Free, Dairy-Free, Sugar-Free Solution to IBD, Celiac Disease, Autism, Cystic Fibrosis, and other ... Conditions (Healthy Living Cookbooks). Fair Winds, 2008.
Знайти повний текст джерелаG, Poór, and Gergely P, eds. Miscellaneous inflammatory musculoskeletal conditions. [Netherland]: Elsevier, 2004.
Знайти повний текст джерелаGyula, Poór, and Gergely Peter, eds. Miscellaneous inflammatory musculoskeletal conditions. London: Baillière Tindall, 2004.
Знайти повний текст джерелаF, Lioté, and Pascual E, eds. Miscellaneous non-inflammatory musculoskeletal conditions. London: Bailliè Tindall, 2003.
Знайти повний текст джерелаЧастини книг з теми "Fibrotic and inflammatory conditions"
Wright, Fred W. "Tracheal and Bronchial Developmental Abnormalities, and Inflammatory Diseases including Bronchiectasis, Cystic Fibrosis and Bronchiolitis." In Radiology of the Chest and Related Conditions, 103–36. London: CRC Press, 2022. http://dx.doi.org/10.4324/9780429272967-3.
Повний текст джерелаOrder, Stanley E., and Sarah S. Donaldson. "Inflammatory Conditions." In Radiation Therapy of Benign Diseases, 176–80. Berlin, Heidelberg: Springer Berlin Heidelberg, 2003. http://dx.doi.org/10.1007/978-3-642-58719-1_61.
Повний текст джерелаCaldarelli, Massimo. "Inflammatory Conditions." In Principles of Pediatric Neurosurgery, 216–26. New York, NY: Springer New York, 1992. http://dx.doi.org/10.1007/978-1-4612-2800-4_16.
Повний текст джерелаDaróczy, Judit. "Inflammatory Conditions." In The Dermal Lymphatic Capillaries, 87–99. Berlin, Heidelberg: Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-73480-9_12.
Повний текст джерелаIbba-Manneschi, Lidia, Irene Rosa, and Mirko Manetti. "Telocytes in Chronic Inflammatory and Fibrotic Diseases." In Advances in Experimental Medicine and Biology, 51–76. Singapore: Springer Singapore, 2016. http://dx.doi.org/10.1007/978-981-10-1061-3_4.
Повний текст джерелаOwens, Scott R., and Henry D. Appelman. "Noninfectious Inflammatory Conditions." In Atlas of Esophagus and Stomach Pathology, 17–25. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-8084-6_3.
Повний текст джерелаOliveira, Margarida Alexandre, and Anna Ciechomska. "Inflammatory Allied Conditions." In Musculoskeletal Ultrasonography in Rheumatic Diseases, 271–313. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-15723-8_12.
Повний текст джерелаAnsell, I. D. "Prostate — Inflammatory Conditions." In Atlas of Male Reproductive Pathology, 69–72. Dordrecht: Springer Netherlands, 1985. http://dx.doi.org/10.1007/978-94-009-4868-6_15.
Повний текст джерелаAnsell, I. D. "Testis — Inflammatory Conditions." In Atlas of Male Reproductive Pathology, 45–48. Dordrecht: Springer Netherlands, 1985. http://dx.doi.org/10.1007/978-94-009-4868-6_9.
Повний текст джерелаRogler, Gerhard. "Challenges of Translation of Anti-Fibrotic Therapies into Clinical Practice in IBD." In Fibrostenotic Inflammatory Bowel Disease, 295–305. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-90578-5_20.
Повний текст джерелаТези доповідей конференцій з теми "Fibrotic and inflammatory conditions"
Kapnisis, Konstantinos, Dina Halwani, Brigitta Brott, Jack Lemons, Peter Anderson, and Andreas Anayiotos. "Stent Overlapping and Geometric Curvature Influence the Structural Integrity and Surface Characteristics of Coronary Stents." In ASME 2012 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2012. http://dx.doi.org/10.1115/sbc2012-80231.
Повний текст джерелаDudas, Paul L., Fang Teng, Karen I. Becker, Patrick F. Wilkinson, Jennifer L. Luongo, Anuk M. Das, and Francis X. Farrell. "Interleukin-1± Pulmonary Pro-Inflammatory / Pro-Fibrotic Activity." In American Thoracic Society 2010 International Conference, May 14-19, 2010 • New Orleans. American Thoracic Society, 2010. http://dx.doi.org/10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a3530.
Повний текст джерелаKamoun, S., N. Khalil, K. A. Johannson, V. Marcoux, M. R. J. Kolb, J. H. Fisher, H. Manganas, C. J. Ryerson, and D. Assayag. "Progressive Fibrotic Interstitial Lung Disease in Autoimmune Inflammatory Myopathy." In American Thoracic Society 2022 International Conference, May 13-18, 2022 - San Francisco, CA. American Thoracic Society, 2022. http://dx.doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2742.
Повний текст джерелаSchmidkonz, C., S. Rauber, A. Atzinger, TI Götz, A. Soare, M. Cordes, O. Prante, et al. "Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imaging." In NuklearMedizin 2021 – digital. Georg Thieme Verlag KG, 2021. http://dx.doi.org/10.1055/s-0041-1726701.
Повний текст джерелаMoraes Ferreira, Renilson, Maysa A R Brandao-Rangel, Anamei Silva-Reis, Thiago G Gibson-Alves, Helida C Aquino-Santos, Victor H Souza-Palmeira, Claudio R Frison, and Rodolfo P Vieira. "Aerobic Training Improves Pulmonary and Systemic Inflammatory and Fibrotic Response in Asthmatics." In ERS International Congress 2021 abstracts. European Respiratory Society, 2021. http://dx.doi.org/10.1183/13993003.congress-2021.oa2935.
Повний текст джерелаCarbajal, M. P., Z. Mark, A. Kumar, N. Daphtary, M. Aliyeva, A. Jegga, J. H. T. Bates, and V. Anathy. "The Anti-Inflammatory, Pro-Fibrotic Role of Osteopontin in Influenza A Infection." In American Thoracic Society 2022 International Conference, May 13-18, 2022 - San Francisco, CA. American Thoracic Society, 2022. http://dx.doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2619.
Повний текст джерелаKamata, Hirofumi, Sasatomo Tasaka, Ken-ichiro Inoue, Naoki Hasegawa, Rina Takamiya, Hirohisa Takano, and Akitoshi Ishizaka. "Carbon Black Nanoparticle Enhances Bleomycin-induced Inflammatory And Fibrotic Changes In The Lung." In American Thoracic Society 2010 International Conference, May 14-19, 2010 • New Orleans. American Thoracic Society, 2010. http://dx.doi.org/10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a1960.
Повний текст джерелаHumphries, B., M. Saunders, S. Cruwys, and B. Humphries. "Inhaled NXP002 attenuates LPS-induced inflammatory and fibrotic mediator production in the rat lung." In ERS International Congress 2022 abstracts. European Respiratory Society, 2022. http://dx.doi.org/10.1183/13993003.congress-2022.2955.
Повний текст джерелаGagnon, L., M. Leduc, M. Tremblay, C. Shimbori, F. Sarra-Bournet, A. Felton, T. Yanagihara, et al. "Anti-Inflammatory/Anti-Fibrotic Compound PBI-4425 Alleviates Bleomycin- and TGF-ß1-Induced Pulmonary Fibrosis." In American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a2389.
Повний текст джерелаDufour, A. M., M. Alvarez, S. Lemeille, M. E. Truchetet, N. C. Brembilla, and C. Chizzolini. "FRI0411 Dual pro-inflammatory and anti-fibrotic role of il-17a in systemic sclerosis skin." In Annual European Congress of Rheumatology, EULAR 2018, Amsterdam, 13–16 June 2018. BMJ Publishing Group Ltd and European League Against Rheumatism, 2018. http://dx.doi.org/10.1136/annrheumdis-2018-eular.6784.
Повний текст джерелаЗвіти організацій з теми "Fibrotic and inflammatory conditions"
Schwartz, Bertha, Vaclav Vetvicka, Ofer Danai, and Yitzhak Hadar. Increasing the value of mushrooms as functional foods: induction of alpha and beta glucan content via novel cultivation methods. United States Department of Agriculture, January 2015. http://dx.doi.org/10.32747/2015.7600033.bard.
Повний текст джерелаChou, Roger, Jesse Wagner, Azrah Y. Ahmed, Ian Blazina, Erika Brodt, David I. Buckley, Tamara P. Cheney, et al. Treatments for Acute Pain: A Systematic Review. Agency for Healthcare Research and Quality (AHRQ), December 2020. http://dx.doi.org/10.23970/ahrqepccer240.
Повний текст джерелаThe Copper T 380 Intrauterine Device: A Summary of Scientific Data. Population Council, 1992. http://dx.doi.org/10.31899/cbr1992.1000.
Повний текст джерела